Are you Aline Semblano Dias Carreira?

Claim your profile

Publications (2)2.06 Total impact

  • Article: Pathologic fracture of jaw in unicystic ameloblastoma treated with marsupialization.
    [show abstract] [hide abstract]
    ABSTRACT: Pathologic fractures may occur when a bone has been weakened by an underlying pathologic process. The treatment depends on the etiology. We report on a patient with pathologic fracture in the jaw caused by unicystic ameloblastoma. The lesion was subjected to marsupialization, and the size of the radiolucent lesion decreased. The fracture was consolidated by bone regeneration. For the remaining tumor, a secondary surgery was performed with enucleation followed by spray cryosurgery using a combination of propane, butane, and isobutane gases. The patient showed no signs of recurrence during the 3-year period after the second surgical procedure.
    The Journal of craniofacial surgery 11/2012; 23(6):e537-9. · 0.81 Impact Factor
  • Article: Use of gas combination cryosurgery for treating ameloblastomas of the jaw.
    [show abstract] [hide abstract]
    ABSTRACT: This study evaluated the results of curettage followed by spray propane, butane, and isobutane gas combination cryosurgery in 10 patients with ameloblastoma. The patients' age ranged from 7 to 87years (mean, 31years), with equal prevalence in both men and women. Five cases were diagnosed as solid ameloblastomas and 5 as unicystic ameloblastomas. Before enucleation and cryosurgery, the unicystic lesions received marsupialisation to decrease their size. No patient showed evidence of clinical or radiographic recurrence, pathologic fracture, or infection after treatment with enucleation and cryosurgery. The most common complication was wound dehiscence, which was observed in all cases. The average follow-up period was 60.5months (range 48-108months). These results show that enucleation followed by cryosurgery is an effective therapy for managing ameloblastomas.
    Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-Maxillo-Facial Surgery 03/2012; · 1.25 Impact Factor